NASDAQ · Medical Devices · USD
Modular Medical, Inc. (MODD) Stock Analysis
Modular Medical, Inc. (MODD) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
MODD Key Statistics
As of Oct 21, 2026Trading
- Open
- $2.00
- Previous Close
- $1.95
- Day's Range
- 1.88–2.09
- 52-Week Range
- 1.72–18.66
- Volume
- 90.68K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.30
Valuation
- Market Cap
- $18.71M
- P/E Ratio
- unprofitable
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −9.95
Financials (FY)
- Revenue (FY)
- $0.00
- Net Income (FY)
- −$28.24M
- Shares Outstanding
- 9.50M
- 1-Year Return
- −89.00%
Dividend and dates
- Avg Volume
- 286.53K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, MODD closed at $1.97, −89.00% over 1 year.
Modular Medical, Inc. (MODD) has a market capitalization of $18.71M.
In fiscal 2025, MODD reported revenue of $0.00.
MODD Stock Return by Calendar Year
Modular Medical, Inc. (MODD) return since Feb 2022: what $10,000 became
- 1 year
- $10,000 $1,100
- −89.00%
- 3 years
- $10,000 $661
- −93.39%
- Since Feb 2022
- $10,000 $177
- −98.23%
If you had invested $10,000 in Modular Medical, Inc. (MODD) at the close on February 10, 2022, the earliest close on record here, it would have been worth $177 at the close on October 21, 2026: −98.23% in total, −57.67% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −81.96% |
| 2025 | −73.43% |
| 2024 | −24.73% |
| 2023 | −9.00% |
| 2022 (partial year) | −46.09% |
As of October 21, 2026.
MODD Revenue and Earnings by Fiscal Year
FY ends March| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $0.00 | −$28.24M | — |
| 2024 | $0.00 | −$18.82M | — |
| 2023 | $0.00 | −$17.47M | — |
| 2022 | $0.00 | −$13.88M | — |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $0.00 | — | −$27.56M | −$28.24M | — |
| 2024 | $0.00 | — | −$19.05M | −$18.82M | — |
| 2023 | $0.00 | — | −$17.53M | −$17.47M | — |
| 2022 | $0.00 | — | −$13.88M | −$13.88M | — |
Annual figures as reported, in the company's reporting currency. As of March 31, 2026.
Recent News
Modular Medical Launches Digital Learning Tools to Support Adoption of Pivot Insulin Delivery System
YahooModular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th
YahooModular Medical, Inc. (MODD) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript
SeekingAlphaModular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026
YahooModular Medical Secures National PBM Contract For Pivot Insulin Pump
YahooModular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump
Yahoo
All 12 articles ↓Show fewer ↑
Modular Medical Receives Contract From Undisclosed U.S. Pharmacy Benefit Manager To Provide Its Insulin Delivery System
BenzingaModular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements
YahooEXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades
YahooEXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades
BenzingaRegistration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday, September 4, 2026
YahooModular Medical Launches Pivot Insulin Delivery System Across Five Key U.S. Markets
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Devices Stocks
Abbott Laboratories
$173.92B
MDTMedtronic plc.
$119.00B
SYKStryker Corporation
$114.15B
BSXBoston Scientific Corporation
$64.33B
EWEdwards Lifesciences Corporation
$50.95B
GEHCGE HealthCare Technologies Inc.
$31.17B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B








